$16.72
Today
as of Sep 4, 16:50 ET
Last 30 days
Recent Press Releases & News
Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference
Integra (IART) Down 1.6% Since Last Earnings Report: Can It Rebound?
Can IART's SurgiMend Relaunch Help Drive a Broader 2027 Recovery?
Overview
52-week range
$8.70
$20
68% of range
Avg surprise (last 3)
+10.6%
Avg reaction (last 2)
+1.5%
50% positive
Latest IV / EM
80%
EM ±12.6% · $18 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.06 | — | — | — | — | financials |
| Tue May 5, 2026 | Mar/2026 | $0.54 | $0.41 | +31.7% | +31.7% | +24.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.07 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $0.45 | $0.43 | +4.7% | — | — | earnings |
| Mon May 5, 2025 | Mar/2025 | $0.41 | $0.43 | -4.7% | — | -21.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.14 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.16 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.04 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.24 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.05 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $0.29 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $419M | $392M | — | $402M | $416M | $383M | — | $381M |
| Cost of revenue | $199M | $175M | — | $195M | $206M | $188M | — | $181M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $19M | $11M | — | $12M | $-513M | $-15M | — | $-8M |
| Net income | $4M | $-5M | — | $-5M | $-484M | $-25M | — | $-11M |
| EPS (diluted) | $0.06 | $-0.06 | — | $-0.07 | $-6.31 | $-0.33 | — | $-0.14 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $214M | $237M | $235M | $232M | $218M | $239M | $246M | $215M |
| Inventory | $492M | $495M | $493M | $489M | $465M | $445M | $429M | $437M |
| Total current assets | $1.19B | $1.17B | $1.16B | $1.14B | $1.14B | $1.11B | $1.08B | $1.10B |
| Total assets | $3.56B | $3.58B | $3.60B | $3.65B | $3.67B | $4.05B | $4.04B | $4.07B |
| Long-term debt | $707M | $717M | — | $736M | $746M | $756M | — | $765M |
| Total liabilities | $2.52B | $2.54B | $2.56B | $2.61B | $2.63B | $2.53B | $2.49B | $2.54B |
| Total equity | $1.04B | $1.04B | $1.04B | $1.04B | $1.04B | $1.52B | $1.55B | $1.52B |